Get access to our best features
Get access to our best features
Published 15 days ago

Johnson & Johnson Shares Hold Steady After Q1 Earnings, Analysts Optimistic About Future - Johnson & Johnson (NYSE:JNJ)

Summary by Benzinga
On Tuesday, Johnson & Johnson (NYSE:JNJ) reported first-quarter adjusted EPS of $2.71, up 12.4% year over year, beating the consensus of $2.64. The pharma giant reported sales of $21.38 billion, up 2.3% year over year, almost in line with the consensus of $21.39 billion. Operational growth was 3.9%, and adjusted operational growth was 4.0%. After good earnings results, Cantor Fitzgerald remains positive on Johnson & Johnson’s stock.  The analyst…

0 Articles

All
Left
Center
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe
Ground News Article Assistant
Not enough coverage to generate an Article Assistant.

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)